The Research and Development team at 35Pharma spearheads the design and development of biologics targeting pulmonary hypertension and musculoskeletal disorders. Utilizing advanced machine learning and data analytics, preclinical studies, and translational research, they aim to innovate and expedite the discovery of effective therapeutic solutions.